CCNT1
Description
The CCNT1 (cyclin T1) is a protein-coding gene located on chromosome 12.
Cyclin-T1 is a protein that in humans is encoded by the CCNT1 gene. The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns that contribute to the temporal coordination of each mitotic event. This cyclin tightly associates with CDK9 kinase, and was found to be a major subunit of the transcription elongation factor p-TEFb. The kinase complex containing this cyclin and the elongation factor can interact with, and act as a cofactor of human immunodeficiency virus type 1 (HIV-1) Tat protein, and was shown to be both necessary and sufficient for full activation of viral transcription. This cyclin and its kinase partner were also found to be involved in the phosphorylation and regulation of the carboxy-terminal domain (CTD) of the largest RNA polymerase II subunit.
CCNT1, also known as Cyclin-T1, is a regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb). P-TEFb facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II). CCNT1 is essential for activating the protein kinase activity of CDK9 by mediating formation of liquid-liquid phase separation (LLPS) that enhances binding of P-TEFb to the CTD of RNA Pol II.
CCNT1 is also known as CCNT, CYCT1, HIVE1.
Associated Diseases
- low grade glioma
- ovarian cancer
- thyroid gland adenocarcinoma
- transient myeloproliferative syndrome
- neutrophil immunodeficiency syndrome
- hemoglobin D disease
- hemoglobin E-beta-thalassemia syndrome
- complement component C1s deficiency